Page last updated: 2024-08-20

dextrothyroxine and Chagas Disease

dextrothyroxine has been researched along with Chagas Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's5 (62.50)2.80

Authors

AuthorsStudies
Balcazar, DE; Carrillo, C; Clausi, AN; Fraccaroli, L; Larocca, L; Perdomo, VG; Ruiz, MD1
Apodaca Michel, B; Du Plessis, JD; Gagyor, I; Gunesch, C; Kasang, C; Navarro, M; Parisi, S; Pritsch, M; Rubilar, G; Saavedra Irala, C; Schrader, H; Schwienhorst-Stich, EM; Shock, J; Zirkel, J; Zoller, T1
Alonso, A; Butts, J; Czachura, J; Reininger, K; Shaughnessy, MK; Thomas, CM1
Carey, JB; Durden, C; Hamer, GL; Hamer, SA; Klemashevich, C; Knape, K; Norman, KN; Tian, Y1
Busselman, RE; Hamer, GL; Hamer, SA; Zecca, IB1
Forsyth, C1
Alonso-Pacheco, ML; González-Ramos, J; Herranz-Pinto, P; Mora-Rillo, M1
Dias, JC; Fernandes, AJ; Machado, EM; Schofield, CJ1

Other Studies

8 other study(ies) available for dextrothyroxine and Chagas Disease

ArticleYear
Broadening the spectrum of ivermectin: Its effect on
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Chagas Disease; Chlorocebus aethiops; Humans; Ivermectin; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells

2022
Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study.
    BMJ open, 2022, 09-17, Volume: 12, Issue:9

    Topics: Adult; Chagas Disease; COVID-19; Cross-Sectional Studies; Humans; Ivermectin; Middle Aged; Pandemics

2022
Evaluation of a Geographic Screening Protocol for Chronic Parasitic Infections Before Kidney Transplant: An Institutional Experience in Minnesota.
    The American journal of tropical medicine and hygiene, 2022, 11-14, Volume: 107, Issue:5

    Topics: Animals; Chagas Disease; Humans; Ivermectin; Kidney Transplantation; Minnesota; Parasites; Parasitic Diseases; Retrospective Studies; Schistosomiasis; Strongyloidiasis; United States

2022
Fluralaner systemic treatment of chickens results in mortality in Triatoma gerstaeckeri, vector of the agent of Chagas disease.
    Parasites & vectors, 2023, Jun-02, Volume: 16, Issue:1

    Topics: Animals; Chagas Disease; Chickens; Fenbendazole; Humans; Insect Vectors; Insecticides; Ivermectin; Triatoma

2023
Canine Systemic Insecticides Fluralaner and Lotilaner Induce Acute Mortality of Triatoma gerstaeckeri, North American Vector of the Chagas Disease Parasite.
    The American journal of tropical medicine and hygiene, 2023, 11-01, Volume: 109, Issue:5

    Topics: Animals; Chagas Disease; Dogs; Humans; Insect Vectors; Insecticides; Ivermectin; North America; Parasites; Triatoma; Trypanosoma cruzi

2023
From Lemongrass to Ivermectin: Ethnomedical Management of Chagas Disease in Tropical Bolivia.
    Medical anthropology, 2018, Volume: 37, Issue:3

    Topics: Anthropology, Medical; Bolivia; Chagas Disease; Cymbopogon; Female; Health Services Accessibility; Humans; Ivermectin; Male; Medicine, Traditional; Middle Aged; Neglected Diseases; Plant Extracts

2018
Need to screen for Chagas disease and Strongyloides infestation in non-endemic countries prior to treatment with biologics.
    Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:4

    Topics: Angioedema; Animals; Antibodies, Helminth; Antibodies, Protozoan; Antiprotozoal Agents; Antirheumatic Agents; Arthritis, Psoriatic; Bolivia; Chagas Disease; Disease Susceptibility; Drug Substitution; Endemic Diseases; Etanercept; Humans; Ivermectin; Nitroimidazoles; Patient Selection; Spain; Strongyloidiasis

2017
Ticks, ivermectin, and experimental Chagas disease.
    Memorias do Instituto Oswaldo Cruz, 2005, Volume: 100, Issue:8

    Topics: Acute Disease; Animals; Antiparasitic Agents; Chagas Disease; Chronic Disease; Dog Diseases; Dogs; Ivermectin; Rhipicephalus sanguineus; Rhodnius; Tick Infestations; Time Factors; Treatment Outcome; Triatoma; Trypanosoma cruzi

2005